Progress in the Treatment of Liver Diseases

Esta obra, publicada en lengua inglesa, presenta las ponencias de la Quinta Reunión Internacional sobre el Tratamiento de las Enfermedades del Hígado.

Como en las anteriores publicaciones, el presente libro tiene como objetivo presentar la información más actual sobre los avances en el manejo y tratamiento de los pacientes con enfermedades del hígado.

La obra ha sido dividida en ocho secciones, en las que se reflejan las complicaciones de la cirrosis; la hepatitis aguda y crónica, fibrosis en la patología hepática, esteatosis hepática no alcohólica y hepatitis alcohólica aguda, tratamiento del carcinoma hepatocelular, transplante de hígado de donante vivo, mantenimiento hepático artificial, y dos capítulos sobre células madre y factores genéticos del huésped, y progreso en el tratamiento de las enfermedades del hígado.

Merece destacar la última sección titulada “Miscelánea”, ya que la investigación en células madre ha sido uno de los más importantes avances científicos en todos los campos, incluyendo la hepatología. Este capítulo se basa en el debate de las células madre y su importancia en el tratamiento de las enfermedades del hígado.

Índice de Capítulos

• Progression of Portal Hypertension: An Analysis of Variants
• Pharmacology of Portal Hypertension: Beyond ß-Blockers
• Vasoconstrictor Therapy. The Hepatorenal Syndrome and Beyond
• Pathogenesis and Treatment of Dilutional Hyponatremia in Cirrhosis
• Bacterial Infections and Antibiotics in Cirrhosis
• Hepatic Encephalopathy in Liver Failure. A Multiorgan Perspective
• Hepatopulmonary Syndrome: Is Medical Therapy Possible?
• Treatment of Hemostatic Disorders in Patients with Liver Disease
• Molecular Antiviral Targets for Hepatitis B Virus: Implications of Escape Mutants, Covalently Closed Circular DNA and Viral Genotypes
• (Peg)Interferon Therapy for Chronic Hepatitis B: Present and Future Options
• Nucleos(t)ide Analogues for the Treatment of Chronic Hepatitis B
• Treatment of Chronic Hepatitis B-2003. Who Should Be Treated? With What and for How Long?
• Combination Pegylated Interferon and Ribavirin Therapy for Hepatitis C Virus in 2003
• Direct Inhibitors of Hepatitis C Virus Replication Functions: Will We Need Interferons for the Treatment of Chronic Hepatitis C?
• Viral Kinetic Assessment to Predict Outcome in HCV Therapy
• Strategies for the Prevention and Treatment of Recurrent Hepatitis C Infection
• Treatment of Hepatitis C Virus and Hepatitis B Virus Infection in the Peritransplant Period
• Extrahepatic Manifestations of HCV Infection
• Acute Hepatitis C: Epidemiology and Treatment
• Mechanisms of Hepatic Stellate Cell Activation
• Regulation of Collagen Expression in Hepatic Stellate Cells
• Exploiting Matrix as a Modulator of Fibrogenesis
• The Renin-Angiotensin System and Liver Fibrosis. Therapeutical Implications
• Natural History of Nonalcoholic Steatohepatitis
• Nonalcoholic Steatohepatitis Pathogenesis
• Diagnosis and Treatment of Nonalcoholic Fatty Liver in Adults
• Pediatric Nonalcoholic Steatohepatitis
• Treatment of Alcoholic Hepatitis
• Epidemiology, Risk Factors and Screening Strategies for Hepatocellular Carcinoma
• Preneoplastic Nodules and Early Hepatocellular Carcinoma. Pathological and Diagnostic Criteria
• Hepatocellular Carcinoma-Current Surgical Management
• Liver Transplantation in Patients with Hepatocellular Carcinoma
• Percutaneous Ablation of Hepatocellular Carcinoma
• Systematic Review of Treatment for Hepatocellular Carcinoma
• Systemic Agents: Present Status and Future Prospects
• Cholangiocarcinoma: Diagnosis and Treatment
• Ethical Issues in Adult Living Donor Liver Transplantation: Too Much, Too Soon
• Adult Living Donor Risk: Measurable - Controlable? Morbidity, Mortality and Future Prospects
• Indications for Living Donor Liver Transplantation: Selective Versus Expanded
• Living Donor Liver Transplantation: The American Experience
• Living Donor Liver Transplantation: The European Experience
• Toxin Removal in Liver Damage and Multiorgan Dysfunction
• Transport Mechanism of Albumin Dialysis: Factors Influencing Efficacy and Selectivity
• Molecular Adsorbents Recirculating System: What Does It Do and How Does It Work
• Effect of Nonbiological Liver Support on Systemic and Cerebral Hemodynamics
• Artificial Liver Support: Overview of Registry and Controlled Clinical Trials
• Prometheus - A New Extracorporeal Liver Support Therapy
• Stem Cells in Future Therapy for Liver Diseases
• Host Generic Factors and the Progression of Liver Diseases